Andros Pharmaceuticals Co.,Ltd (6917.TWO)
TWD 14.95
(-18.31%)
TWD 14.95
(-18.31%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 58.03 Million TWD | 15.81% |
| 2022 | 50.11 Million TWD | -2.89% |
| 2021 | 51.6 Million TWD | -18.07% |
| 2020 | 62.98 Million TWD | 5.17% |
| 2019 | 59.88 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 FY | 58.03 Million TWD | 15.81% |
| 2023 Q2 | 46.6 Million TWD | -7.0% |
| 2023 Q4 | 58.03 Million TWD | 24.53% |
| 2022 Q4 | 50.11 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -729.84% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 90.053% |
| Level Biotechnology Inc. | 273.2 Million TWD | 78.756% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 57.889% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 70.609% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 95.629% |
| GlycoNex Incorporation | 276.39 Million TWD | 79.002% |
| VBI | 21.25 Million TWD | -173.112% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 81.499% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 88.723% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -173.434% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 84.243% |
| Visgeneer Inc. | 185.6 Million TWD | 68.73% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 95.614% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 92.082% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 51.578% |
| Neith Corporation | 17.43 Million TWD | -232.926% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 97.416% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -776.987% |
| Enimmune corporation | 173.46 Million TWD | 66.541% |
| TaiRx, Inc. | 60.62 Million TWD | 4.266% |
| CHO Pharma, Inc. | 110.83 Million TWD | 47.633% |
| EirGenix Inc. | 1.14 Billion TWD | 94.932% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 48.171% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 88.674% |
| Lin BioScience, Inc. | 167.73 Million TWD | 65.397% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 38.068% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | 7.924% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 53.468% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 63.964% |
| RBC Bioscience Corporation | 513.08 Million TWD | 88.688% |
| BiOptic Inc. | 170.56 Million TWD | 65.972% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -37.67% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -149.576% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -116.458% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 94.045% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -628.036% |
| NaviFUS Corp. | 53.4 Million TWD | -8.685% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 87.946% |
| Sinew Pharma Inc. | 39.71 Million TWD | -46.142% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 84.076% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 74.51% |
| AP Biosciences Inc | 106.65 Million TWD | 45.58% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 98.356% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -89.169% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 70.387% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 96.239% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 93.301% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -525.69% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -3.988% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 75.086% |
| TCI GENE Inc. | 155.54 Million TWD | 62.687% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -127.533% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -25.694% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 82.331% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 10.554% |
| PharmaEngine, Inc. | 91 Million TWD | 36.225% |
| Savior Lifetec Corporation | 457.95 Million TWD | 87.327% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 47.684% |
| OBI Pharma, Inc. | 650.44 Million TWD | 91.077% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 85.149% |
| Acepodia, Inc. | 384.47 Million TWD | 84.904% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 32.16% |